renal biopsy interpretation

Transcription

renal biopsy interpretation
RENAL BIOPSY
INTERPRETATION
(for the MRCPath Exam.)
Dr Bruce Lyons
Consultant Histopathologist
Derriford Hospital
Biopsy handling
•
•
•
•
2 cores
2-3 gloms- IMF/P
2-3 gloms- EM
Rest of tissue- Paraffin
Cutting & Staining
•
•
•
•
•
•
•
Paraffin Serials
H&E: S1 S10 S20
Sliver (Gomori)
PAS
MSB (fibrin)
EVG
Congo Red
Cutting & Staining
Immunohistochemistry
• IMF (Frozen)
• IMP (Frozen or
Paraffin)
•
•
•
•
•
IgA
IgG
IgM
C3
C1q
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy / HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Diffuse Membranous GN
Diffuse Mesangio-capillary GN
Diffuse Endocapillary prolif. GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
?????????
IgA
IgG
Writing a report
•
Introduction
•
Glomeruli
•
Tubules & Interstitium
•
Vessels
•
Immunohistochemistry
•
Electron Microscopy
•
Conclusion/Comments:
Renal cases for MRCPath.
(the beauty of the Exam. Case)
• ‘Barn-door’ examples
(morphology)
• +/- Common 2° conditions
(esp. vascular)
• ‘Normal’ (looking)
Gathering the information
• ‘Barn-door’ examples
(morphology)
• +/- Common 2° conditions
(esp. vascular)
• ‘Normal’ (looking)
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy / HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Diffuse Membranous GN
Diffuse Mesangio-capillary GN
Diffuse Endocapillary prolif. GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Diffuse Membranous GN
Diffuse mesangio-capillary GN
Diffuse endocapillary prolif. GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
IgA
IgG
podocyte
endothelial cell
* podocyte
lamina densa
lamina rara externa
lamina rara interna
endothelial cell *
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Diffuse Membranous GN
Diffuse mesangio-capillary GN
Diffuse endocapillary prolif. GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
TIN vs. Infection
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Membranous GN
Mesangio-capillary GN
Endocapillary proliferative GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
Myeloma cast nephropathy
•
•
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
Tubular “Thyroidisation”
Myeloma Cast Nephropathy
Myeloma Cast Nephropathy
Myeloma Cast Nephropathy
• MYELOMA
• ‘Hard’, cracked casts
• Giant-cell reaction
• “Thyroidisation”
(chronicity)
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Membranous GN
Mesangio-capillary GN
Endocapillary proliferative GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
Essential hypertension
•
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
Diabetes Mellitus
• Nodular sclerotic lesion:
Kimmelstiel-Wilson (KW)
nodule
• Global (“diffuse”)
sclerotic lesion:
Diabetes Mellitus
DM:
‘Capsular drop’
CR
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Membranous GN
Mesangio-capillary GN
Endocapillary proliferative GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN
ATN vs. Ascending infection
•
Essential hypertension
•
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus
Essential HTN
Afferent hyaline arteriolosclerosis
Essential HTN
Large arteries: Arteriosclerosis
Essential HTN
Medium-sized arteries: Medial hypertrophy
Essential HTN
Medium & Small arteries: Internal elastic reduplication
Essential HTN
Medium & Small arteries: Internal elastic reduplication
Essential HTN
Afferent hyaline arteriolosclerosis
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Membranous GN
Mesangio-capillary GN
Endocapillary proliferative GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN
ATN vs. Ascending infection
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
•
•
Vasculitis
Renovascular disease/Embolus
Thrombotic Microangiopathy (TMA)
• 4 causes (for the exam!)
•
•
•
•
Malignant HTN
HUS
TTP
Screroderma ‘crisis’
Thrombotic Microangiopathy (TMA)
• “Acute” TMA
• TMA heals with “onionskinning” (myxoid
fibroblastic thickening)
ATN
• Can be overlooked
(“normal-looking”
biopsy)… but not in the
exam!
Cases for final MRCPath exam.
•
•
•
•
•
•
IgA nephropathy/ HenochSchonlein Purpura
Pauci-immune crescentic GN
(Wegener’s, Microscopic PAN)
Anti-GBM GN (“Goodpasture’s”)
Lupus (WHO III, IV, V esp)
Membranous GN
Mesangio-capillary GN
Endocapillary proliferative GN
•
•
•
•
Minimal Change
Alport’s
Thin membrane nephropathy
[Amyloid/Light chain nephropathy]
•
•
FSGS
•
•
•
Myeloma cast nephropathy
TIN vs. Ascending infection
ATN
•
•
Essential hypertension
Diabetes mellitus
•
•
•
•
•
•
Malignant hypertension
HUS
TTP
Scleroderma
Vasculitis
Renovascular disease/Embolus

Similar documents